Bristol Myers holder plans sale of 6,249 shares

Planned Rule 144 sale of 6,249 Bristol Myers Squibb common shares by an insider following restricted stock vesting.

Rhea-AI Filing Summary

BRISTOL MYERS SQUIBB CO (BMY) received a Rule 144 notice for a proposed sale of common stock by Cristian Massacesi. The filing covers 6,249 shares of common stock to be sold through Fidelity Brokerage Services LLC, with an indicated aggregate market value of $403,497.93 and a proposed sale date of September 9, 2026 on the NYSE.

The shares to be sold arise from restricted stock vesting on August 1, 2026 as compensation from the issuer. The notice is signed by Jessica Spraker as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Cristian Massacesi.

Key Figures

Shares to be sold: 6,249 shares Aggregate market value: $403,497.93 Proposed sale date: September 9, 2026 +2 more

5 metrics

Shares to be sold 6,249 shares Common stock covered by the Rule 144 notice

Aggregate market value $403,497.93 Value associated with the 6,249 shares proposed for sale

Proposed sale date September 9, 2026 Date for the planned Rule 144 sale on the NYSE

Restricted stock vesting date August 1, 2026 Date the compensation-related restricted stock vested

Security type Common stock Class of Bristol Myers Squibb securities to be sold

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 08/01/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing for BMY disclose?

It discloses that Cristian Massacesi intends to sell 6,249 shares of Bristol Myers Squibb (BMY) common stock under Rule 144, through Fidelity Brokerage Services LLC, following restricted stock vesting on August 1, 2026.

How many BMY shares are covered by this Rule 144 notice?

The notice covers 6,249 shares of Bristol Myers Squibb common stock. These shares are planned for sale through Fidelity Brokerage Services LLC under Rule 144 and stem from a restricted stock vesting event dated August 1, 2026.

What is the aggregate market value of the BMY shares in this Form 144?

The filing lists an aggregate market value of $403,497.93 for the 6,249 shares of Bristol Myers Squibb common stock covered by the planned Rule 144 sale through Fidelity Brokerage Services LLC.

When are the BMY shares expected to be sold under this Form 144?

The proposed sale date disclosed is September 9, 2026, with the 6,249 shares of Bristol Myers Squibb common stock to be sold on the NYSE through Fidelity Brokerage Services LLC under Rule 144.

How did the reporting person obtain the BMY shares to be sold?

The filing states the shares result from Restricted Stock Vesting on August 1, 2026, received as compensation from Bristol Myers Squibb, and these vested shares are the ones covered by the planned Rule 144 sale.

Who is acting on behalf of the seller in the BMY Form 144?

The notice is signed by Jessica Spraker as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Cristian Massacesi in connection with the planned Rule 144 sale of Bristol Myers Squibb shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 10:28 AM Accepted by SEC EDGAR 09/09/2026 - 10:27 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002080176
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BRISTOL MYERS SQUIBB CO
SEC File Number	001-01136
Address of Issuer	ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NEW JERSEY 08543
Phone	6092524621
Name of Person for Whose Account the Securities are To Be Sold	Massacesi Cristian
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6249	403497.93	2042714656	09/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2026	Restricted Stock Vesting	Issuer			6249	08/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Cristian Massacesi.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)